Roche launches top selling eye drug Vabysmo in India

Roche Pharma India launches Vabysmo, a medication for neovascular age-related macular degeneration and diabetic macular edema in India. The drug is cost-effective and collaborates with government and insurance companies for patient access. Vabysmo achieves global sales and offers durable treatment for retinal vision loss.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news